Literature DB >> 11819812

Acute variceal bleeding: general management.

D Patch1, L Dagher.   

Abstract

Mesh：

Year:  2001        PMID： 11819812      PMCID： PMC4688656          DOI： 10.3748/wjg.v7.i4.466

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  95 in total

1.  Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding.

Authors:  P Calès; N Lacave; C Silvain; J P Vinel; K Besseghir; D Lebrec
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

2.  Transjugular portosystemic shunts in pediatric patients awaiting liver transplantation.

Authors:  S P Johnson; J R Leyendecker; F B Joseph; A E Joseph; D C Diffin; D Devoid; J Eason
Journal:  Transplantation       Date:  1996-10-27       Impact factor: 4.939

3.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  J Goulis; A Armonis; D Patch; C Sabin; L Greenslade; A K Burroughs
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

4.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

Authors:  J Saló; A Ginès; J C Quer; G Fernández-Esparrach; M Guevara; P Ginès; R Bataller; R Planas; W Jiménez; V Arroyo; J Rodés
Journal:  J Hepatol       Date:  1996-12       Impact factor: 25.083

6.  Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience.

Authors:  C A Hackworth; J A Leef; J D Rosenblum; P F Whitington; J M Millis; E M Alonso
Journal:  Radiology       Date:  1998-01       Impact factor: 11.105

7.  Bacterial infection in the pathogenesis of variceal bleeding.

Authors:  J Goulis; D Patch; A K Burroughs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

8.  Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.

Authors:  A Hadengue; A Gadano; R Moreau; E Giostra; F Durand; D Valla; S Erlinger; D Lebrec
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

9.  Prognostic factors in upper G.I. bleeding.

Authors:  F T de Dombal; J R Clarke; S E Clamp; G Malizia; M R Kotwal; A G Morgan
Journal:  Endoscopy       Date:  1986-05       Impact factor: 10.093

10.  A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices.

Authors:  R Shields; S A Jenkins; J N Baxter; A N Kingsnorth; S Ellenbogen; C A Makin; I Gilmore; A I Morris; D Ashby; C R West
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083
View more
  3 in total

1.  Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

Authors:  Seung Up Kim; Ji Hoon Lee; Do Young Kim; Sang Hoon Ahn; Kyu Sik Jung; Eun Hee Choi; Young Nyun Park; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

2.  Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia.

Authors:  Seung Min Hahn; Seung Kim; Kook In Park; Seok Joo Han; Hong Koh
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

3.  Supersonic shearwave elastography in the assessment of liver fibrosis for postoperative patients with biliary atresia.

Authors:  Shuling Chen; Bing Liao; Zhihai Zhong; Yanling Zheng; Baoxian Liu; Quanyuan Shan; Xiaoyan Xie; Luyao Zhou
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.